Infinium Pharmachem IPO GMP, Review, Price, Allotment


Last updated on October 25, 2023

Infinium Pharmachem IPO GMP

Infinium Pharmachem IPO description – Incorporated in 2003, Infinium Pharmachem aims to manufacture and supply Iodine, Iodine Derivatives, and Active Pharmaceutical Ingredients (APIs).

The company undertakes contract research and manufacturing services to provide customized and fully confidential solutions to its clients. Today, its manufacturing capabilities and technical expertise has allowed it to efficiently cater to numerous industries such as pharmaceutical & biotech, specialty & Performance chemicals, agrochemicals, human health, animal health, cosmetics, sanitation, electrical, electronics, and much more.

Its manufacturing plant in Gujarat, provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs.

Infinium Pharmachem Factory

Promoters of Infinium Pharmachem – Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya

Infinium Pharmachem IPO Details

Infinium Pharmachem IPO Dates31 March – 5 April 2023
Infinium Pharmachem IPO PriceINR 135 per share
Fresh issue18,75,000 shares (INR 25.31 crore)
Offer For SaleNil
Total IPO size18,75,000 shares (INR 25.31 crore)
Minimum bid (lot size)1,000 shares (INR 135,000)
Face Value INR 10 per share
Retail Allocation50%
Listing OnNSE SME

Infinium Pharmachem Financial Performance

 FY 2020FY 2021FY 2022H1 FY 2023
Net income0.872.736.696.0
Figures in INR Crores unless specified otherwise

Infinium Pharmachem Offer News

Infinium Pharmachem Valuations & Margins

FY 2020FY 2021FY 2022
PE ratio11.24
RONW (%)21.9938.8046.61
ROCE (%)
EBITDA (%)7.887.9111.07
*Compiled by IPO Central from Prospectus

Infinium Pharmachem IPO GMP Today

DateConsolidated IPO GMPKostakSubject to Sauda
17 Apr 20233
15 Apr 20233
13 Apr 20233
12 Apr 20234
11 Apr 20234
7 Apr 20235
6 Apr 20235
5 Apr 20235
3 Apr 20235

Infinium Pharmachem IPO Subscription – Live Updates

CategoryNon retailRetailTotal
Shares Offered937,500937,5001,875,000
5 Apr 20231.821.861.84
3 Apr 20230.310.550.43
31 Mar 20230.060.090.08

Infinium Pharmachem Offer Lead Manager

Flat No.18, 2nd Floor, North Wing,
Madhaveshwar Co-op- Hsg Society Ltd, Madhav Nagar, 1
1/12, S. V. Road, Andheri W, Mumbai– 400058
Phone: +91 22-26254568-69
Email: [email protected]

Infinium Pharmachem Offer Registrar

Office No. S6-2, 6th Floor,
Pinnacle Business Park,
Next to Ahura Centre, Mahakali
Caves Road, Andheri East,
Mumbai – 400 093
Telephone: +91 22 6263 8200
Email: [email protected]

Infinium Pharmachem Contact Details

Suite 205, Sigma Prime, 2nd Floor,
Nr. Sardar Patel Statue Vallabh Vidhyanagar,
Dist. Anand – 388120, Gujarat
Phone: +91 (2692) 238849, 238850, 297446
E-mail: [email protected]

Infinium Pharmachem IPO Allotment Status

Infinium Pharmachem IPO allotment status is now available on Bigshare Services’ website. Click on Bigshare Services weblink to get allotment status.

Infinium Pharmachem IPO Dates & Listing Performance

IPO Opening Date31 March 2023
IPO Closing Date5 April 2023
Finalisation of Basis of Allotment11 April 2023
Initiation of refunds12 April 2023
Transfer of shares to demat accounts13 April 2023
Infinium Pharmachem IPO Listing Date17 April 2023
Opening Price on NSE SMEINR 141.50 per share (up 4.81%)
Closing Price on NSE SMEINR 147.80 per share (up 9.48%)

Infinium Pharmachem IPO FAQs

What is Infinium Pharmachem offer size?

Infinium Pharmachem offer size is INR 25.31 crore.

What is Infinium Pharmachem IPO Price Band?

Infinium Pharmachem public offer price is INR 135 per share.

What is the lot size of Infinium Pharmachem IPO?

Infinium Pharmachem offer a lot size is 1,000 shares.

What is Infinium Pharmachem IPO GMP today?

Infinium Pharmachem IPO GMP today is INR 3 per share.

What is Infinium Pharmachem kostak rate today?

Infinium Pharmachem kostak rate today is NA per application.

What is Infinium Pharmachem Subject to Sauda rate today?

Infinium Pharmachem Subject to Sauda rate today is INR NA per application.



Please enter your comment!
Please enter your name here